Patents Assigned to Taylor Pharmaceuticals
  • Compositions and method for treating migraine
    Patent number: 5997884
    Abstract: An aqueous solution of droperidol suitable for injection having a concentration from about 0.1 to about 10.0 mg/ml, and a sufficient amount of tonicity adjusting agent to render the solution isotonic, the solution being in a sealed container. Also provided is an aqueous solution of droperidol suitable for injection, comprising droperidol at a concentration from about 2.75 to about 10 mg/ml, and the solution being in a sealed container.
    Type: Grant
    Filed: February 12, 1998
    Date of Patent: December 7, 1999
    Assignee: Taylor Pharmaceuticals
    Inventors: Abu Alam, Pablo J. Diaz Cruz, Keith Glad, Dennis Roberts
  • Oral droperidol compositions and method for treating migraine
    Patent number: 5990134
    Abstract: Oral dosage form of droperidol are provided and a method for treating migraine using such oral formulations. The dosage forms include tablets, capsules, powders, effervescent formulations and syrups.
    Type: Grant
    Filed: August 12, 1998
    Date of Patent: November 23, 1999
    Assignee: Taylor Pharmaceuticals
    Inventor: Abu Alam
  • Sublingual and buccal compositions of droperidol and method for treating migraine
    Patent number: 5981552
    Abstract: Sublingual and buccal dosage forms of droperidol are provided in a method for treating migraine using such formulations.
    Type: Grant
    Filed: October 23, 1998
    Date of Patent: November 9, 1999
    Assignee: Taylor Pharmaceuticals
    Inventor: Abu Alam
  • Method of treating migraine
    Patent number: 5977145
    Abstract: Intravenous or intramuscular injection of droperidol is disclosed to treat migraine episodes.
    Type: Grant
    Filed: February 12, 1998
    Date of Patent: November 2, 1999
    Assignee: Taylor Pharmaceuticals
    Inventors: Stephen D. Silberstein, William B. Young